2-Naphthacene-7-t-carboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,[4S-(4a,4aa,5aa,6b,12aa)]- (9CI) (36051-40-8)

Identification
Name:	2-Naphthacene-7-t-carboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,[4S-(4a,4aa,5aa,6b,12aa)]- (9CI)
Synonyms:	7-Tritiotetracycline;Tetracycline-7-3H; Tetracycline-7-t
CAS:	36051-40-8
Molecular Formula:	C22H23 N2 O8 T
Molecular Weight:	446.44
Molecular Structure:
Properties
Safety Data

Other Product

2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-piperidinylmethyl)-,monohydrochloride, [4S-(4a,4aa,5aa,6b,12aa)]- (9CI)
2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrochloride, [4S-(4a,4aa,5aa,6b,12aa)]- (9CI)
Sulfamic acid, dodecyl-, compd.with [4S-(4a,4aa,5a,5aa,12aa)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide(1:1) (9CI)
2-Naphthacenecarboxamide,6-[[(3-chloropropyl)thio]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-,[4S-(4a,4aa,5a,5aa,6a,12aa)]- (9CI)
2-Naphthacenecarboxamide,N-[[bis(2-chloroethyl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,[4S-(4a,4aa,5aa,6b,12aa)]- (9CI)
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-6-[(propylthio)methyl]-,[4S-(4a,4aa,5a,5aa,6a,12aa)]- (9CI)
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,sodium salt, [4S-(4a,4aa,5a,5aa,6b,12aa)]- (9CI)
2-Naphthacenecarboxamide,7-chloro-6-[(2,6-dideoxy-3-C-methyl-4-O-methyl-a-L-arabino-hexopyranosyl)oxy]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-methyl-1,11-dioxo-,[4R-(4a,4aa,5aa,6a,12aa)]- (9CI)
Carbamic acid,(2,5-dichlorophenyl)-,3-(aminocarbonyl)-1-(dimethylamino)-1,6,11,11a,12,12a-hexahydro-2,5,7,11,12-pentahydroxy-11-methyl-4,6-dioxo-4a(4H)-naphthacenylester, [1S-(1a,4aa,11b,11aa,12a,12aa)]- (9CI)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-
Acetic acid, [(6-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamid
1,12(4H,5H)-Naphthacenedione,2-acetyl-4-amino-4a,5a,6,12a-tetrahydro-3,6,10,11,12a-pentahydroxy-6,9-dimethyl-,[4S-(4a,4aa,5aa,6b,12aa)]- (9CI)
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
2-Naphthacenecarboxamide,6-[[3-[(acetyloxy)amino]-2,3,6-trideoxy-3-C-methyl-4-O-methyl-a-L-arabino-hexopyranosyl]oxy]-7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-methyl-1,11-dioxo-,[4R-(4a,4aa,5aa,6a,12aa)]- (9CI)
2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-methyl-1,11-dioxo-6-[[2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-a-L-arabino-hexopyranosyl]oxy]-,[4R-(4a,4aa,5aa,6a,12aa)]- (9CI)
2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-methyl-1,11-dioxo-6-[[2,3,6-trideoxy-3-(hydroxyamino)-3-C-methyl-4-O-methyl-a-L-arabino-hexopyranosyl]oxy]-,[4R-(4a,4aa,5aa,6a,12aa)]- (9CI)
Metaphosphoric acid (HPO3), compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (4:3), monosodium salt
Sulfamic acid, cyclohexyl-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
2,4-Hexadienoic acid, (E,E)-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
Sulfuric acid, monododecyl ester, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)